Medicofarma Biotech SA (WSE:MDB)

Market Cap	33.51M
Revenue (ttm)	281.45K
Net Income (ttm)	-3.06M
Shares Out	67.98M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,259
Average Volume	26,529
Open	0.4740
Previous Close	0.4680
Day's Range	0.4560 - 0.4970
52-Week Range	0.2310 - 1.4000
Beta	1.07
RSI	45.64
Earnings Date	Nov 10, 2025

About Medicofarma Biotech

Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in Feb...

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2001
• Employees: 20
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MDB

Financial Performance

In 2024, Medicofarma Biotech's revenue was 1.22 million, an increase of 63.14% compared to the previous year's 750,809. Losses were -2.30 million, -33.11% less than in 2023.